View in EDS HTML Full Text PDF Full Text

Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study.

Saved in:
Bibliographic Details
Title: Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study.
Authors: Megna, Matteo1 (AUTHOR) mat24@libero.it, Ruggiero, Angelo1 (AUTHOR), Martora, Fabrizio1 (AUTHOR), Vallone, Ylenia1 (AUTHOR), Guerrasio, Gianluca1 (AUTHOR), Potestio, Luca1 (AUTHOR)
Source: Journal of Clinical Medicine. May2024, Vol. 13 Issue 9, p2691. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm13092691